Stay updated on TQ05105 Tablets in Refractory aGVHD Clinical Trial
Sign up to get notified when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.

Latest updates to the TQ05105 Tablets in Refractory aGVHD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference13%

- Check28 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive changes.SummaryDifference0.3%

- Check42 days agoChange Detected- Revision updated from v3.0.1 to v3.0.2; no other substantive content changes are evident. - The 'Back to Top' control was removed.SummaryDifference0.8%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.8%

- Check56 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference7%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to TQ05105 Tablets in Refractory aGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.